Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 3412074, 9 pages
https://doi.org/10.1155/2018/3412074
Review Article

Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents among Herbal Medicines

1Department of Clinical Oncology, Cheonan Korean Medicine Hospital of Daejeon University, 4, Notaesan-ro, Seobuk-gu, Cheonan-si, No. 31099, Republic of Korea
2Liver and Immunology Research Center, Dunsan Korean Medicine Hospital of Daejeon University, 75, Daedeok-daero 176beon-gil, Seo-gu, Daejeon-si, No. 35235, Republic of Korea
3Department of Internal Medicine, Graduated School of Korean Medicine, University of Daejeon, 62, Daehak-ro, Dong-gu, Daejeon-si, No. 34520, Republic of Korea

Correspondence should be addressed to Namhun Lee; rk.ujd@eelhn

Received 17 April 2018; Revised 24 July 2018; Accepted 2 August 2018; Published 12 August 2018

Academic Editor: María C. Carpinella

Copyright © 2018 Gayoung Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, S. A. Fedewa et al., “Colorectal cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 67, no. 3, pp. 177–193, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. Fojo, K. Ueda, D. J. Slamon, D. G. Poplack, M. M. Gottesman, and I. Pastan, “Expression of a multidrug-resistance gene in human tumors and tissues,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 84, no. 1, pp. 265–269, 1987. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Krishna and L. D. Mayer, “Multidrug resistance (MDR) in cancerMechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs,” European Journal of Pharmaceutical Sciences, vol. 11, no. 4, pp. 265–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Chai, K. K. To, and G. Lin, “Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines,” Chinese Medicine, vol. 5, no. 1, p. 26, 2010. View at Publisher · View at Google Scholar
  5. V. Goler-Baron, I. Sladkevich, and Y. G. Assaraf, “Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells,” Biochemical Pharmacology, vol. 83, no. 10, pp. 1340–1348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. B. Longley and P. G. Johnston, “Molecular mechanisms of drug resistance,” The Journal of Pathology, vol. 205, no. 2, pp. 275–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Gottesman, “Mechanisms of cancer drug resistance,” Annual Review of Medicine, vol. 53, pp. 615–627, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. G.-T. Ho, F. M. Moodie, and J. Satsangi, “Multidrug resistance 1 gene (P-glycoprotein 170): An important determinant in gastrointestinal disease?” Gut, vol. 52, no. 5, pp. 759–766, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Bansal, M. Jaggi, R. K. Khar, and S. Talegaonkar, “Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 12, no. 1, pp. 46–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Ellis, J. W. Marlin, T. A. H. Taylor et al., “The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model,” Journal of Pharmacy and Pharmacology, vol. 67, no. 2, pp. 178–188, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham, “Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 84, no. 21, pp. 7735–7738, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Potočnik, M. Ravnik-Glavač, R. Golouh, and D. Glavač, “Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: Correlation with microsatellite instability and lymphoid infiltration in colorectal cancers [4],” Journal of Medical Genetics, vol. 39, no. 5, pp. 340–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yamada, A. S. Takaoka, and Y. Naishiro, “Transactivation of the Multidrug Resistance 1 Gene by T-Cell Factor 4/(beta)-Catenin Complex in Early Colorectal Carcinogenesis,” Cancer Research, vol. 60, no. 17, pp. 4761–4766, 2000. View at Google Scholar
  14. R. L. Juliano and V. Ling, “A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants,” Biochimica et Biophysica Acta, vol. 455, no. 1, pp. 152–162, 1976. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Esser, F. Zhou, K. M. Pluchino et al., “Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity,” The Journal of Biological Chemistry, vol. 292, no. 2, pp. 446–461, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. A. K. Tiwari, K. Sodani, C.-L. Dai, C. R. Ashby Jr., and Z.-S. Che, “Revisiting the ABCs of multidrug resistance in cancer chemotherapy,” Current Pharmaceutical Biotechnology, vol. 12, no. 4, pp. 570–594, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Eichhorn and T. Efferth, “P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs,” Journal of Ethnopharmacology, vol. 141, no. 2, pp. 557–570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Wang, C. Xie, Y. Huang, C. W. K. Lam, and M. S. S. Chow, “Overcoming chemotherapy resistance with herbal medicines: Past, present and future perspectives,” Phytochemistry Reviews, vol. 13, no. 1, pp. 323–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Gu, G. Zhang, Z. Su, and F. Ouyang, “Identification of major active constituents in the fingerprint of Salvia miltiorrhiza Bunge developed by high-speed counter-current chromatography,” Journal of Chromatography A, vol. 1041, no. 1-2, pp. 239–243, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-Y. Yu, S.-G. Lin, Z.-W. Zhou et al., “Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge,” Current Drug Metabolism, vol. 8, no. 4, pp. 325–340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Hu, K. K. W. To, L. Wang et al., “Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza,” Phytomedicine, vol. 21, no. 11, pp. 1264–1272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. W.-D. Lu, Y. Qin, C. Yang, L. Li, and Z.-X. Fu, “Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo,” Clinics, vol. 68, no. 5, pp. 694–701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Ampasavate, U. Sotanaphun, P. Phattanawasin, and N. Piyapolrungroj, “Effects of Curcuma spp. on P-glycoprotein function,” Phytomedicine, vol. 17, no. 7, pp. 506–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Liu, Z.-J. Duan, J.-Y. Chang et al., “Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression,” PLoS ONE, vol. 9, no. 6, Article ID e98560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-U. Choi, S.-H. Park, K.-H. Kim et al., “The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein,” Anti-Cancer Drugs, vol. 9, no. 3, pp. 255–261, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Yuan, X. Shi, Y. Qiu et al., “Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin,” Oncology Reports, vol. 37, no. 3, pp. 1815–1825, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. D. Min, M. C. Yang, K. H. Lee, K. R. Kim, S. U. Choi, and K. R. Lee, “Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino,” Archives of Pharmacal Research, vol. 29, no. 9, pp. 757–761, 2006. View at Publisher · View at Google Scholar
  28. S. B. Syed, H. Arya, I. Fu et al., “Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  29. L. Jiumao, The Effect and Mechanism of Hedyotis Diffusa Willd Reverse Multi-drug Resistance in Colorectal Cancer [Ph.D. thesis], Chinese Medicine, Fujian University, 2016.
  30. X. D. Jin, Q. L. Xu, and X. Z. Zheng, “Reversal Effect of ?-Schisandrin Compound on Multidrug Resistance of Human Carcinoma of Colon Cell THC-8307,” Med. Recapitul, vol. 10, pp. 3–5, 2011. View at Google Scholar
  31. J. Cao, X. Chen, J. Liang et al., “Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra,” Drug Metabolism and Disposition, vol. 35, no. 4, pp. 539–553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. B.-B. Huang, G.-F. Li, F. Ren et al., “Effect of Glycyrrhiza inflata and Daphne genkwa on permeabilities of rhodamine 123, a P-glycoprotein substrate across rat jejunum membranes in vitro,” Zhongguo Zhong Yao Za Zhi, vol. 33, no. 21, pp. 2521–2526, 2008. View at Google Scholar
  33. P. H. H. Leung, L. Zhang, Z. Zuo, and G. Lin, “Intestinal absorption of Stemona alkaloids in a Caco-2 cell model,” Planta Medica, vol. 72, no. 3, pp. 211–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Han, L. M. Bu, X. Ji, C. Y. Liu, and Z. H. Wang, “Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line,” Journal of Digestive Diseases, vol. 6, no. 2, pp. 82–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. X.-Y. Yu, Z.-W. Zhou, S.-G. Lin et al., “Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza,” Xenobiotica, vol. 37, no. 4, pp. 375–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. U. Kukongviriyapan, K. Apaijit, and V. Kukongviriyapan, “Oxidative stress and cardiovascular dysfunction associated with cadmium exposure: Beneficial effects of curcumin and tetrahydrocurcumin,” The Tohoku Journal of Experimental Medicine, vol. 239, no. 1, pp. 25–38, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Sinha, D. E. Anderson, S. S. McDonald, and P. Greenwald, “Cancer risk and diet in India,” J. Postgrad. Med, vol. 49, no. 3, pp. 222–228, 2003. View at Google Scholar
  38. J. Choi, C. Oh, S. Shim, S. Jeong, H. S. Kim, and M. Kim, “Reduction in Prevalence of Hypertension and Blood Heavy Metals among Curry-Consumed Korean,” The Tohoku Journal of Experimental Medicine, vol. 244, no. 3, pp. 219–229, 2018. View at Publisher · View at Google Scholar
  39. G. G. L. Yue, S.-W. Cheng, H. Yu et al., “The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal caco-2 cells,” Journal of Medicinal Food, vol. 15, no. 3, pp. 242–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Yamasaki, “Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum,” Acta Medica Okayama, vol. 30, no. 1, pp. 1–20, 1976. View at Google Scholar · View at Scopus
  41. K. Chan, Z. Q. Liu, Z. H. Jiang et al., “The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model,” Journal of Ethnopharmacology, vol. 103, no. 3, pp. 425–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Lin, J. Lv, P. Peng et al., “Bufadienolides induce p53-mediated apoptosis in esophageal squamous cell carcinoma cells in vitro and in vivo,” Oncology Letters, vol. 15, no. 2, pp. 1566–1572, 2018. View at Google Scholar · View at Scopus
  43. J. Lan, Y. Zhao, F. Dong et al., “Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension,” Journal of Ethnopharmacology, vol. 161, pp. 69–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Meghwal and T. K. Goswami, “Piper nigrum and piperine: An update,” Phytotherapy Research, vol. 27, no. 8, pp. 1121–1130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Darshan and R. Doreswamy, “Patented antiinflammatory plant drug development from traditional medicine,” Phytotherapy Research, vol. 18, no. 5, pp. 343–357, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J.-H. Ye, M.-H. Liu, X.-L. Zhang, and J.-Y. He, “Chemical profiles and protective effect of Hedyotis diffusa willd in lipopolysaccharide-induced renal inflammation mice,” International Journal of Molecular Sciences, vol. 16, no. 11, pp. 27252–27269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Yao, X. Liu, and Y. Gu, “Schisandra chinensis Baill, a Chinese medicinal herb, alleciates high-fat-diet-including non-alcoholic steatohepatitis in rats,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 11, no. 1, pp. 222–227, 2014. View at Google Scholar
  48. C. Liu, S. Zhang, and H. Wu, “Non-thermal extraction of effective ingredients from Schisandra chinensis baill and the antioxidant activity of its extract,” Natural Product Research (Formerly Natural Product Letters), vol. 23, no. 15, pp. 1390–1401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. Chen, Y. J. Wu, N. N. Cheng et al., “Dual effects of extract of Schisandra chinensis Baill on rat hepatic CYP3A,” Acta Pharmaceutica Sinica B, vol. 45, no. 9, pp. 1194–1198, 2010. View at Google Scholar
  50. V. L. M. Madgula, B. Avula, Y. W. Choi et al., “Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers—an in-vitro model of intestinal transport,” Journal of Pharmacy & Pharmacology, vol. 60, no. 3, pp. 363–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Fukai, K. Satoh, T. Nomura, and H. Sakagami, “Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra,” Fitoterapia, vol. 74, no. 7-8, pp. 624–629, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. H.-S. Chung, P.-M. Hon, G. Lin, P. P.-H. But, and H. Dong, “Antitussive Activity of Stemona Alkaloids from Stemona tuberosa,” Planta Medica, vol. 69, no. 10, pp. 914–920, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Subramanian, M. Z. Asmawi, and A. Sadikun, “In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide,” Acta Biochimica Polonica, vol. 55, no. 2, pp. 391–398, 2008. View at Google Scholar · View at Scopus
  54. X.-Y. Hu, R.-H. Wu, M. Logue et al., “Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis,” PLoS ONE, vol. 12, no. 8, 2017. View at Google Scholar · View at Scopus
  55. R. A. Kumar, K. Sridevi, N. V. Kumar, S. Nanduri, and S. Rajagopal, “Anticancer and immunostimulatory compounds from Andrographis paniculata,” Journal of Ethnopharmacology, vol. 92, no. 2-3, pp. 291–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Wilkens, “Structure and mechanism of ABC transporters,” F1000Prime Reports, vol. 7, pp. 1–9, 2015. View at Google Scholar
  57. S. Meschini, A. Calcabrini, E. Monti et al., “Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells,” International Journal of Cancer, vol. 87, no. 5, pp. 615–628, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai, “Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil,” Cancer Research, vol. 41, no. 5, pp. 1967–1972, 1981. View at Google Scholar · View at Scopus
  59. A. H. Dantzig, D. P. De Alwis, and M. Burgess, “Considerations in the design and development of transport inhibitors as adjuncts to drug therapy,” Advanced Drug Delivery Reviews, vol. 55, no. 1, pp. 133–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. M. V. S. Varma, Y. Ashokraj, C. S. Dey, and R. Panchagnula, “P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement,” Pharmacological Research, vol. 48, no. 4, pp. 347–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Thomas and H. M. Coley, “Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein,” Cancer Control, vol. 10, no. 2, pp. 159–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Li, H. Zhang, Y. G. Assaraf et al., “Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies,” Drug Resistance Updates, vol. 27, pp. 14–29, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Artursson, K. Palm, and K. Luthman, “Caco-2 monolayers in experimental and theoretical predictions of drug transport,” Advanced Drug Delivery Reviews, vol. 22, no. 1-2, pp. 67–84, 1996. View at Publisher · View at Google Scholar
  64. V. Meunier, M. Bourrié, Y. Berger, and G. Fabre, “The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications,” Cell Biology and Toxicology, vol. 11, no. 3-4, pp. 187–194, 1995. View at Publisher · View at Google Scholar · View at Scopus